Drugs / JTT-252
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02120976 | Apr 2014 → Feb 2015 | diabetes mellitus | Akros Pharma Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JTT-252 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02120976 ↗ |
| Route | Oral | “single oral doses of JTT-252” NCT02120976 ↗ |